CDC20 together with CENPA, CDK1, AURKA, and TPX2 were also diagnostic biomarkers in LUAD, and elevated mRNA levels of CDC20 were correlated with poor prognosis of lung cancer (48, 49). This evidence concerns the gene CDC20 and lung carcinoma.